Literature DB >> 1803784

[The sensitivity of different experimental animals to the Marburg virus].

N I Gonchar, V A Pshenichnov, V A Pokhodiaev, K L Lopatov, I V Firsova.   

Abstract

Mesh：

Year:  1991        PMID： 1803784

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN： 0507-4088


× No keyword cloud information.
  8 in total

1.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

Review 2.  Progress in filovirus vaccine development: evaluating the potential for clinical use.

Authors:  Darryl Falzarano; Thomas W Geisbert; Heinz Feldmann
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

3.  Disease modeling for Ebola and Marburg viruses.

Authors:  Dennis Bente; Jason Gren; James E Strong; Heinz Feldmann
Journal:  Dis Model Mech       Date:  2009 Jan-Feb       Impact factor: 5.758

4.  Development and characterization of a mouse model for Marburg hemorrhagic fever.

Authors:  Kelly L Warfield; Steven B Bradfute; Jay Wells; Loreen Lofts; Meagan T Cooper; D Anthony Alves; Daniel K Reed; Sean A VanTongeren; Christine A Mech; Sina Bavari
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

5.  Postexposure treatment of Marburg virus infection.

Authors:  Thomas W Geisbert; Lisa E Hensley; Joan B Geisbert; Anders Leung; Joshua C Johnson; Allen Grolla; Heinz Feldmann
Journal:  Emerg Infect Dis       Date:  2010-07       Impact factor: 6.883

Review 6.  Animal models for filovirus infections.

Authors:  Vinayakumar Siragam; Gary Wong; Xiang-Guo Qiu
Journal:  Zool Res       Date:  2018-01-18

Review 7.  Forty-five years of Marburg virus research.

Authors:  Kristina Brauburger; Adam J Hume; Elke Mühlberger; Judith Olejnik
Journal:  Viruses       Date:  2012-10-01       Impact factor: 5.048

Review 8.  Animal models for Ebola and Marburg virus infections.

Authors:  Eri Nakayama; Masayuki Saijo
Journal:  Front Microbiol       Date:  2013-09-05       Impact factor: 5.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.